News for Champions Oncology, Inc. (CSBR)

HACKENSACK, NJ / ACCESS Newswire / April 28, 2025 / Champions Oncology (NASDAQ:CSBR), a leader in translational oncology research, has been granted a license to

HACKENSACK, NJ / ACCESS Newswire / April 24, 2025 / Champions Oncology (NASDAQ:CSBR), a global leader in oncology R&D solutions, has announced a strategic colla

Champions Oncology, Inc. (CSBR) has entered into a strategic alliance with Turbine, aiming to transform drug discovery workflows in the biopharmaceutical indust

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NCSBR.OQ - Champions Oncology IncQ3 2025 Champions Oncology Inc Earnings CallMar 11, 2025 / 08:

Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2025 Earnings Conference Call March 11, 2025 4:30 PM ETCompany ParticipantsRonnie Morris - CEODavid Miller -...

HACKENSACK, NJ / ACCESS Newswire / March 6, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that off

HACKENSACK, NJ / ACCESS Newswire / February 18, 2025 / Champions Oncology Inc. (NASDAQ:CSBR), a global leader in preclinical oncology research and clinical spec

Transaction Overview On December 31, 2024, Tocqueville Asset Management L.P. made a strategic decision to reduce its holdings in Champions Oncology Inc (NASDAQ:

CSBR stock hits 52-week high at $9.94 amid growth

CSBR stock touches 52-week high at $8.92 amid robust growth

HACKENSACK, NJ / ACCESSWIRE / December 11, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offe

Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2024 Earnings Conference Call December 11, 2024 4:30 PM ETCompany ParticipantsRonnie Morris - Chief Executive...

Revenue: $14.1 million, an increase of 12% from the first quarter of 2024.Income from Operations: $1.3 million, compared to a loss of $2.6 million in the prior

Sep 11, 2024 / 08:30PM GMTOperator Greetings. Welcome to the Champions Oncology first quarter fiscal year 2025 earnings call. (Operator Instructions) Please not

Jul 18, 2024 / 08:30PM GMTOperator Greetings. Welcome to Champions Oncology's fourth quarter fiscal year 2024 earnings conference call. (Operator Instructions)

Craig-Hallum upgraded Champions Oncology (CSBR) to buy, commenting that it sees the CRO returning to revenue predictability over the next couple of quarters. Read more here.

California-based Tenon Medical, Inc. (TNON), a medical device company is up over 160 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Operator: Greetings. Welcome to the Champions Oncology First Quarter Fiscal Year 2025 Earnings Call. At this time, all participants are in a listen-only mode.

Shares of Champions Oncology, Inc. CSBR rose sharply in today's pre-market trading reported better-than-expected financial results for the first quarter on Wedn...